Navigation Links
Z Trim Announces Revocation of Gregory Halpern Severence Agreement
Date:8/31/2007

MUNDELEIN, Ill., Aug. 31 /PRNewswire-FirstCall/ -- Z Trim Holdings, Inc. (Amex: ZTM), today announced that Gregory Halpern has exercised his right to revoke the Resignation Agreement and Release he signed on August 20, 2007.

Under the Agreement, Mr. Halpern would have received severance pay equal to three months' salary plus unused vacation and would have received health insurance benefits for a period of six months. In addition, under the Agreement the Company would have received a release of claims from Mr. Halpern.

Mr. Halpern's revocation of the Agreement does not affect his prior resignation as an officer and director of the Company and does not affect the Board of Directors' previous forfeiture of Mr. Halpern's stock options under the Company's 2004 Equity Incentive Plan.

About Z Trim

USDA-developed Z Trim is a natural non-caloric functional food ingredient that can lower calories from fat up to 80% in foods while maintaining superior taste and mouth feel. Z Trim provides the texture of fats without the calories and can substantially reduce harmful trans fats, saturated fats, and cholesterol, and contributes to a healthy diet. Z Trim is used to reduce fats and maintain moisture for the dairy, bakery, and meat and poultry industries. It is also used in over 50,000 meals a day in schools participating in the nation's School Meals Program. Z Trim food technology provides a natural solution to global challenges of obesity and associated health problems. http://www.ztrim.com

Forward-Looking Statements and Risk Factors

Statements made in this news release that relate to future plans, events or performances are forward-looking statement
'/>"/>

SOURCE Z Trim Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. PM announces a new health care order for India
2. PowderMed Announces Needle-Less Flu Vaccine
3. Ramdoss Announces Introduction of RCH-II
4. Britain Announces Third Transfusion Related Mad Cow Case
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
9. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...er & Olsen LLP has filed a,class action lawsuit ag..."Company") (Nasdaq: ARTC ) and certain of its off...istrict of Texas on behalf of all persons or,entit... January 24, 2008,through July 18, 2008 (the "Comm...or entities who purchased call options or sold put...
(Date:7/25/2008)... therapy may be due to genetic factors , ... challenges the long-held belief that the hepatiti...y to restore itself after HIV patients are treated.... , From 50 percent to 90 percent of HIV-infect...ous drug use is the main cause of both types of in...
(Date:7/25/2008)...ity.com announces the,availability of Trade Alerts... all of the daily trading notes for free by visiti...erts include: DUSA Pharmaceuticals Inc. (Nasdaq: ... MBRK ), NovaMed Inc. (Nasdaq:,NOVA), Adolor Corp....) and,Abaxis Inc. (Nasdaq: ABAX )., Join investo...
(Date:7/25/2008)...mprovements in Members, Health, ATLANTA, July 25 ...h,care quality management solutions for health pla...nto a long-term agreement with Wellmark, Inc. to,c...lity(SM) Incent and,Reward Best Practices initiati...are clinicians to promote improved quality health ...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3
...ypothermia by following a few tips on dressing wel...o feel you've got to stay indoors when the weather...ll do you a lot of good.// But it's important to d...ts of cold weather. Just putting on a woolly scarf...
...ng to a recent survey, researchers suggests that n...rgery assessments of patients to the same degree o...in the UK// and it's been suggested that appropria...some of their roles. Researchers in Ireland, UK, h...
...ng to a latest research it has been observed that ...d three quarters of teenage girls in juvenile dete...der. In a recent study, 2023 juvenile teens were ...hey were admitted to a temporary juvenile detentio...
...ng to a recent study it has been observed that yog...condition of those with heart disease. Yoga exerci...iritual //health - or so it is claimed. Researcher...and, reviewed the best evidence they could find on...
Other Medicine News:
(Date:7/22/2008)...- Strong efficacy results from a multi-center 293-...com , Toronto Stock Exchange Symbol: CYT, MONTRE...echnologies,Inc., the global leader in cryotherapy...unced that results previously presented from three...roduct, Arctic Front(R),were published earlier to...
(Date:7/22/2008)...tudy Demonstrates Feasibility and Efficacy of Trea...y Liver Cancer, SAN FRANCISCO, and YONGIN-SI, Sou...San Francisco, CA and Ottawa, Ontario), and its So...day that novel findings from,a Phase I clinical tr...nstrated that the product was well-tolerated and r...
(Date:7/22/2008)...SOUTH SAN FRANCISCO, Calif., July 22 /PRNewswire/ ...t it has completed patient enrollment,in its Phase...bility and,ammonia scavenging effects of HPN-100 (...henylbutyrate) in patients with urea cycle disorde...esults in the fourth quarter,of this year., (Logo...
(Date:7/22/2008)...SOPHIA ANTIPOLIS, France, July 22 /PRNewswire-Firs...nnounced it has successfully completed the,enrollm...olled hypertension,in two clinical pharmacology st...y announced timelines. These trials are designed t..., in comparison to ibuprofen and,naproxen, using t...
Breaking Medicine Technology:CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Nightingale announces US 2412 3 million sale of its Therapist Helper business 13183 1Nightingale announces US 2412 3 million sale of its Therapist Helper business 13183 2Nightingale announces US 2412 3 million sale of its Therapist Helper business 13183 3Nightingale announces US 2412 3 million sale of its Therapist Helper business 13183 4Congressman Walberg Awarded for Protecting Medicare Choices 13181 1Two Faced Particles Act Like Tiny Submarines 3636 1Two Faced Particles Act Like Tiny Submarines 3636 2Two Faced Particles Act Like Tiny Submarines 3636 3Computer simulations point to key molecular basis of cystic fibrosis 2364 1Computer simulations point to key molecular basis of cystic fibrosis 2364 2
...tatistically Significant Clinical Results for,SB-5...athy, CHICAGO, June 22, 2007 /PRNewswire-FirstCall... presentation of encouraging,Phase 1 clinical data...Scientific Sessions of the American Diabetes Assoc... entitled, "Improved,Neurologic Exam and Nerve Con...
... Symptoms Negatively Affect Relationship, BOCA RAT... a new,nationwide survey show that more than half ...dical condition known as low,testosterone incorrec...The survey also found that, while women believe th...gatively impact their,relationship, treatment of t...
Other Medicine Technology:Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 2Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 3Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 4Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 5Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 6Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 7Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 8Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 9New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging 2New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging 3New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging 4New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging 5
Specially designed for rugged use; perfect tool with power and endurance. Balance of weight and power helps reduce user fatigue. Internally lubricated for longer serivce. Switch is designed and place
De Soutter supply clean cast removal saws that are low in voltage and contain an integrated extractor system, combining state-of-the-art ergonomics with performance and durability.
...he osteotomy staples is quite similar to the type ...e the inner position of the anti recoil contours a...lique staples). There are 3 kinds of staples: 1.... staples can have 3 different widths: 20mm, 26 mm ...
...e Barium Sulfate USP is specifically designed to p...pabilities for todays medical professionals who ad...y. Comprised of a uniform particle size, Biotrace ...lting in a consistent visualization of bone cement...
Medicine Products: